Literature DB >> 22710725

De novo thrombus on an atrial septal defect device 3 years after its implantation.

Olawale O Olabiyi1, David L S Morales, Wayne J Franklin.   

Abstract

The secundum atrial septal defect (ASD) is noted to occur in 1 per 1,500 live births and is the fourth most common congenital heart defect (CHD) [Anzai et al. in Am J Cardiol 93:426-431, 2004]. Early complications with percutaneous closure of secundum ASDs include device malposition and embolization, arrhythmias (primarily atrial fibrillation), pericardial effusion, residual shunt, and thrombus development on the left atrial disk [Chessa et al. in J Am Coll Cardiol 39:1061-1065, 2002, Co-Burn and William in Moss and Adams' Heart disease in infants, children and adolescents including fetus and young adults. Williams and Wilkins, Baltimore, 1995]. We present a patient with a very late complication of device thrombus after percutaneous secundum ASD device closure.

Entities:  

Mesh:

Year:  2012        PMID: 22710725     DOI: 10.1007/s00246-012-0379-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

Review 1.  Thrombus formation on an atrial septal defect closure device: a case report and review of the literature.

Authors:  Dimitar Divchev; Arnd Schaefer; Martin Fuchs; Thomas Breymann; Helmut Drexler; Gerd Peter Meyer
Journal:  Eur J Echocardiogr       Date:  2005-12-06

2.  [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].

Authors:  K La Rosée; D Krause; M Becker; D J Beuckelmann; H J Deutsch; H W Höpp
Journal:  Dtsch Med Wochenschr       Date:  2001-09-21       Impact factor: 0.628

3.  Early and late complications associated with transcatheter occlusion of secundum atrial septal defect.

Authors:  Massimo Chessa; Mario Carminati; Gianfranco Butera; Roberta Margherita Bini; Manuela Drago; Luca Rosti; Alessandro Giamberti; Giuseppe Pomè; Eduardo Bossone; Alessandro Frigiola
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

Review 4.  Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.

Authors:  Ulrike Krumsdorf; Stefan Ostermayer; Kai Billinger; Thomas Trepels; Elisabeth Zadan; Kathrin Horvath; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

5.  Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices.

Authors:  Hitoshi Anzai; John Child; Barbara Natterson; Janine Krivokapich; Michael C Fishbein; Vicki K Chan; Jonathan M Tobis
Journal:  Am J Cardiol       Date:  2004-02-15       Impact factor: 2.778

  5 in total
  1 in total

1.  Huge thrombus formation 1 year after percutaneous closure of an atrial septal defect with an Amplatzer septal occluder.

Authors:  Fahrettin Uysal; Özlem Mehtap Bostan; Işık Şenkaya Sığnak; Mustafa Güneş; Ergün Çil
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.